These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 11972576

  • 1. Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine.
    Dowson AJ, MacGregor EA, Purdy RA, Becker WJ, Green J, Levy SL.
    Cephalalgia; 2002 Mar; 22(2):101-6. PubMed ID: 11972576
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Part II: clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraine.
    Loder EW, Dowson AJ, Spierings EL.
    Curr Med Res Opin; 2005 Mar; 21 Suppl 3():S8-12. PubMed ID: 16083518
    [Abstract] [Full Text] [Related]

  • 6. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
    Rothner AD, Wasiewski W, Winner P, Lewis D, Stankowski J.
    Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
    [Abstract] [Full Text] [Related]

  • 7. Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.
    Dowson AJ, Charlesworth BR.
    Int J Clin Pract; 2003 Sep; 57(7):573-6. PubMed ID: 14529055
    [Abstract] [Full Text] [Related]

  • 8. Part III: the convenience of, and patient preference for, zolmitriptan orally disintegrating tablet.
    Dowson AJ, Almqvist P.
    Curr Med Res Opin; 2005 Sep; 21 Suppl 3():S13-7. PubMed ID: 16083519
    [Abstract] [Full Text] [Related]

  • 9. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L.
    CNS Drugs; 2005 Sep; 19(2):125-36. PubMed ID: 15697326
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Part IV: effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: a post-marketing surveillance study in Germany.
    Diener HC, Gendolla A.
    Curr Med Res Opin; 2005 Sep; 21 Suppl 3():S18-24. PubMed ID: 16083520
    [Abstract] [Full Text] [Related]

  • 13. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study.
    Geraud G, Compagnon A, Rossi A, COZAM Study Group.
    Eur Neurol; 2002 Sep; 47(2):88-98. PubMed ID: 11844897
    [Abstract] [Full Text] [Related]

  • 14. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey.
    MacGregor EA, Brandes J, Eikermann A.
    Headache; 2003 Jan; 43(1):19-26. PubMed ID: 12864754
    [Abstract] [Full Text] [Related]

  • 15. Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.
    Lines C, Visser WH.
    Int J Clin Pract; 2004 Mar; 58(3):322; author reply 322-3. PubMed ID: 15117106
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group.
    Pascual J, Vega P, Diener HC, Allen C, Vrijens F, Patel K.
    Cephalalgia; 2000 Jun; 20(5):455-61. PubMed ID: 11037741
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study.
    Loder E, Silberstein SD, Abu-Shakra S, Mueller L, Smith T.
    Headache; 2004 Feb; 44(2):120-30. PubMed ID: 14756849
    [Abstract] [Full Text] [Related]

  • 18. Review of zolmitriptan and its clinical applications in migraine.
    Dowson AJ, Charlesworth B.
    Expert Opin Pharmacother; 2002 Jul; 3(7):993-1005. PubMed ID: 12083998
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
    Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK.
    Lancet; 2008 Dec 20; 372(9656):2115-23. PubMed ID: 19036425
    [Abstract] [Full Text] [Related]

  • 20. Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study.
    Gruffyd-Jones K, Kies B, Middleton A, Mulder LJ, Røsjø Ø, Millson DS.
    Eur J Neurol; 2001 May 20; 8(3):237-45. PubMed ID: 11328332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.